About Catalyst Clinical Research
Catalyst Clinical Research is a company based in Durham (United States) founded in 2013 was acquired by NovaQuest Capital Management in October 2018. The company has 2 employees as of December 31, 2021. Catalyst Clinical Research has completed 3 acquisitions, including Aptus Clinical, Genpro Research and Triangle Biostatistics. Catalyst Clinical Research offers products and services including Catalyst Oncology and Catalyst Flex. Catalyst Clinical Research operates in a competitive market with competitors including Celgene, Medelis WCCT Global, Syneos Health, Emmes and Parexel, among others.
- Headquarter Durham, United States
- Employees 2 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
2
as on Dec 31, 2021
-
Investments & Acquisitions
Aptus Clinical
& 2 more
-
Acquired by
NovaQuest Capital Management
(Oct 31, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Catalyst Clinical Research
Catalyst Clinical Research offers a comprehensive portfolio of products and services, including Catalyst Oncology and Catalyst Flex.
Provides full-service oncology CRO for cancer drug development.
Offers specialized clinical operations and data management solutions.
People of Catalyst Clinical Research
Unlock access to complete
Data Analysis and Operations Team
26 people
Software Development Team
24 people
Finance and Accounting
17 people
Leadership Team
16 people
Statistical Team
11 people
Sales and Marketing
10 people
Manager Team
10 people
Senior Team
9 people
Unlock access to complete
Funding Insights of Catalyst Clinical Research
Detailed funding history for Catalyst Clinical Research
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Catalyst Clinical Research
Catalyst Clinical Research has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include NovaQuest Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm focused on life science and healthcare companies
|
Locked | Locked | Locked |
Investor details for Catalyst Clinical Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Catalyst Clinical Research
Catalyst Clinical Research has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aptus Clinical, Genpro Research and Triangle Biostatistics.
Investment portfolio details for Catalyst Clinical Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
NLP, software development, and big data services are provided.
|
Locked | Locked | 2016 | Locked | |
|
Auxiliary clinical development services are provided to biopharmaceutical firms.
|
Locked | Locked | 2014 | Locked | |
|
Data management and biostatistics services for drug development are provided.
|
Locked | Locked | 2010 | Locked |
Complete acquisition details for Catalyst Clinical Research
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Catalyst Clinical Research
Detailed financials for Catalyst Clinical Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Catalyst Clinical Research Comparisons
Peer comparison for Catalyst Clinical Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Catalyst Clinical Research
Catalyst Clinical Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celgene, Medelis WCCT Global, Syneos Health, Emmes and Parexel, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
Full-service clinical research organization services are provided globally by Parexel.
|
|
| Locked | Locked | Locked |
Global full-service CRO services are delivered in over 80 countries.
|
Detailed competitors of Catalyst Clinical Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Catalyst Clinical Research
Complete news archive for Catalyst Clinical Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Catalyst Clinical Research
Catalyst Clinical Research was founded in 2013.
Catalyst Clinical Research is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Niklas Morton is the current CEO of Catalyst Clinical Research.
As of Dec 31, 2021, the latest employee count at Catalyst Clinical Research is 2.
Catalyst Clinical Research was founded in 2013 in Durham, United States, as a full-service clinical research organization. Operations focus on conducting trials across Phases I to IV within the healthcare sector. Services encompass clinical trial management, data management, biostatistics, medical writing, pharmacovigilance, and remote data review. The organization supports various trial needs in a structured manner.
Catalyst Clinical Research's top competitors include Emmes, Syneos Health and ClinChoice.
Catalyst Clinical Research offers Catalyst Oncology and Catalyst Flex.
Catalyst Clinical Research has made 3 acquisitions, including Aptus Clinical, Genpro Research, and Triangle Biostatistics.
Catalyst Clinical Research has 1 investor. Key investors include NovaQuest Capital Management.